MALACRIDA, ALESSIO
MALACRIDA, ALESSIO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies
2024 Meregalli, C; Chiorazzi, A; Argentini, A; Ballarini, E; Canta, A; Carozzi, V; Malacrida, A; Marmiroli, P; Tarasiuk, O; Cavaletti, G
Neurodegeneration: can metabolites from Eremurus persicus help?
2024 Cavalloro, V; Marchesi, N; Linciano, P; Rossi, D; Campagnoli, L; Fossati, A; Ahmed, K; Malacrida, A; Miloso, M; Mazzeo, G; Abbate, S; Longhi, G; Ambrosio, F; Costa, G; Alcaro, S; Pascale, A; Martino, E; Collina, S
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma
2024 Rivara, M; Nicolini, G; Malacrida, A; Re, F; Incerti, M; Russo, G; Zuliani, V
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction
2024 Malacrida, A; Tarasiuk, O; Rodriguez-Menendez, V; Stanga, S; Pero, M; Bartolini, F; Nicolini, G; Cavaletti, G; Meregalli, C
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES
2024 Fabbro, V; Malacrida, A; Iseppon, F; Tarasiuk, O; Pero, M; Bartolini, F; Mauri, M; Stanga, S; Cavaletti, G; Meregalli, C
The Role of NMNAT2/SARM1 in Neuropathy Development
2024 Tarasiuk, O; Molteni, L; Malacrida, A; Nicolini, G
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent
2023 Malacrida, A; Deschamps-Wright, M; Rigolio, R; Cavaletti, G; Miloso, M
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons
2023 Meregalli, C; Malacrida, A; Pero, M; Rumora, A; Cartelli, D; Nicolini, G; Feldman, E; Bartolini, F; Cavaletti, G
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity
2023 Pozzi, E; Ballarini, E; Rodriguez Menendez, V; Canta, A; Chiorazzi, A; Monza, L; Bossi, M; Alberti, P; Malacrida, A; Meregalli, C; Scuteri, A; Cavaletti, G; Carozzi, V
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses
2023 Benincasa, L; Molesti, E; Manenti, A; Montomoli, E; Malacrida, A; Zuliani, V; Rivara, M; Nicolini, G; Di Domizio, A
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS
2022 Semperboni, S; Malacrida, A; Rumora, A; Cartelli, D; Monza, L; Pero, M; Rodrguez-Menendez, V; Nicolini, G; Bartolini, F; Feldman, E; Cavaletti, G; Meregalli, C
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells
2022 Malacrida, A; Erriquez, J; Hashemi, M; Rodriguez-Menendez, V; Cassetti, A; Cavaletti, G; Miloso, M
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells
2022 Listro, R; Malacrida, A; Ambrosio, F; Rossino, G; Di Giacomo, M; Cavalloro, V; Garbagnoli, M; Linciano, P; Rossi, D; Cavaletti, G; Costa, G; Alcaro, S; Miloso, M; Collina, S
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin
2022 Alberti, P; Ballarini, E; Malacrida, A; Pozzi, E; Rodriguez-Menendez, V; Monza, L; Chiorazzi, A; Canta, A; Nicolini, G; Scuteri, A; Marmiroli, P; Cavaletti, G
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines
2022 Malacrida, A; Di Domizio, A; Bentivegna, A; Cislaghi, G; Messuti, E; Tabano, S; Giussani, C; Zuliani, V; Rivara, M; Nicolini, G
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity
2022 Alberti, P; Ballarini, E; Malacrida, A; Pozzi, E; Rodriguez-Menendez, V; Monza, L; Chiorazzi, A; Canta, A; Nicolini, G; Scuteri, A; Marmiroli, P; Cavaletti, G
Rigosertib and cholangiocarcinoma: A cell cycle affair
2022 Malacrida, A; Cavaletti, G; Miloso, M
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
2022 Ballarini, E; Malacrida, A; Rodriguez Menendez, V; Pozzi, E; Canta, A; Chiorazzi, A; Monza, L; Semperboni, S; Meregalli, C; Carozzi, V; Hashemi, M; Nicolini, G; Scuteri, A; Housley, S; Cavaletti, G; Alberti, P
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa—part 2
2021 Malacrida, A; Cavalloro, V; Martino, E; Costa, G; Ambrosio, F; Alcaro, S; Rigolio, R; Cassetti, A; Miloso, M; Collina, S
In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells
2021 Malacrida, A; Rigolio, R; Celio, L; Damian, S; Cavaletti, G; Mazzaferro, V; Miloso, M